Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
952.00    5.00 (0.53%)
Bid:
950.80
Ask:
955.20
Spread: 4.40 (0.463%)
Market Cap: £9.40b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Publication of a Prospectus

13 Apr 2026 13:39

RNS Number : 2438A
Wise PLC
13 April 2026
 

13 April 2026 

Wise plc

("Wise")

 

Publication of UK Prospectus

 

Wise today announces that the UK Financial Conduct Authority (the "FCA") has approved and Wise Group plc has published a UK Prospectus for the proposed admission of Wise Group plc's Class A ordinary shares to the equity shares (transition) category of the FCA's Official List and to trading on the Main Market of the London Stock Exchange (the "LSE") (the "Proposed Admission"). The Proposed Admission supports Wise's proposal to move its primary listing to the United States on Nasdaq and maintain a secondary listing in the United Kingdom on the LSE.

 

A copy of the UK Prospectus will shortly be available on Wise's website at https://wise.com/owners/wise-dual-listing and uploaded to the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Expected Timetable of Principal Events

 

A summary of the expected timetable of principal events from the UK Prospectus is set out below.

 

Event

Expected Time / Date

Publication of the UK Prospectus

13 April 2026

Court Hearing (to be held at 7 Rolls Building, Fetter Lane, London EC4A 1NL)(1)

27 April 2026

Last day of dealings in, and for registration of transfers of, Wise plc Class A Shares

8 May 2026

Scheme Record Time

6.30 p.m. (London time) on 8 May 2026

Scheme Effective Time

10.00 p.m. (London time) on 8 May 2026

De-listing of Wise plc Class A Shares from the equity shares (transition) category of the Official List in the United Kingdom

8.00 a.m. (London time) on 11 May 2026

Admission of Wise Group plc Class A Shares to the equity shares (transition) category of the Official List and to trading on the Main Market in the United Kingdom

8.00 a.m. (London time) on 11 May 2026

Commencement of trading in Wise Group plc Class A Shares on Nasdaq in the United States

9.30 a.m. (New York time) on 11 May 2026

 

(1) The time of the Court Hearing will be confirmed and published on the Business and Property Courts Rolls Building Cause List at https://www.court-tribunal-hearings.service.gov.uk/summary-of-publications?locationId=111 on the day before the Court Hearing.

 

Capitalised terms used in this announcement, unless otherwise defined, have the same meanings as set out in the UK Prospectus.

 

All dates and times are based on Wise's current expectations and are subject to change. If any of the dates and/or times in this expected timetable change, the revised dates and/or times will be notified to our owners by announcement through a Regulatory Information Service, with such announcement being made available on Wise's website.

 

Enquiries

Martin Adams - Investor Relations

owners@wise.com

 

Sana Rahman - Communications

press@wise.com

 

Brunswick Group

Charles Pretzlik / Emily Murphy

Wise@brunswickgroup.com

+44 (0) 20 7404 5959

 

About Wise

 

Wise is a global technology company, building the best way to move and manage the world's money.

 

With Wise Account and Wise Business, people and businesses can hold 40+ currencies, move money between countries and spend money abroad. Large companies and banks use Wise technology too; an entirely new network for the world's money. Launched in 2011, Wise is one of the world's fastest growing, profitable tech companies.

 

In fiscal year 2025, Wise supported around 15.6 million people and businesses, processing over £145 billion ($185 billion) in cross-border transactions and saving customers around £2 billion ($2.6 billion).

 

FORWARD LOOKING DISCLOSURE DISCLAIMER

This report may include forward-looking statements, which are based on current expectations and projections about future events. These statements may include, without limitation, any statements preceded by, followed by or including words such as "forward looking", "guidance", "target", "believe", "expect", "intend", "may", "anticipate", "estimate", "forecast," , "project", "will", "can have", "likely", "should", "would", "could" and any other words and terms of similar meaning or the negative thereof. These forward-looking statements are subject to risks, uncertainties and assumptions about Wise and its subsidiaries. In light of these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur. 

Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation that trends or activities underlying past performance will continue in the future, and the statements in this report speak only as at the date of this report. No representation or warranty is made or will be made that any forward-looking statement will come to pass ​​and there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements.

Wise expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statements contained in this report and disclaims any obligation to update its view of any risks or uncertainties described herein or to publicly announce the results of any revisions to the forward-looking statements made in this report, whether as a result of new information, future developments or otherwise, except as required by law.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDILXLFFQZLXBBQ
Date   Source Headline
3rd Jul 20268:33 amRNSTotal Voting Rights
26th Jun 20267:00 amRNSWise FY26 Results
15th Jun 20264:45 pmRNSNotice of FY26 results and Q1 FY27 trading update
3rd Jun 20264:25 pmRNSHolding(s) in Company
2nd Jun 202611:44 amRNSTotal Voting Rights
1st Jun 20268:59 amRNSWise Europe
11th May 202611:00 amRNSWise debuts US listing on Nasdaq
11th May 20268:00 amRNSTotal Voting Rights
11th May 20268:00 amRNSCancellation - Wise plc
11th May 20267:00 amRNSScheme of Arrangement becomes effective
6th May 202612:43 pmRNSDirector/PDMR Shareholding
1st May 20261:55 pmRNSTotal Voting Rights
27th Apr 20263:33 pmRNSScheme of Arrangement
24th Apr 20261:07 pmRNSDirector/PDMR Shareholding
23rd Apr 20262:49 pmRNSTotal Voting Rights
22nd Apr 20263:13 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:32 pmRNSHolding(s) in Company
16th Apr 20264:01 pmRNSDirector/PDMR Shareholding
13th Apr 20261:39 pmRNSPublication of a Prospectus
13th Apr 20267:53 amRNSQ4 FY2026 Trading Update
13th Apr 20267:01 amRNSTranslation of IFRS financials into US GAAP
13th Apr 20267:00 amRNSQ4 FY2026 Trading Update
9th Apr 20269:05 amRNSNotice of Q4 FY2026 Results
1st Apr 20262:50 pmRNSTotal Voting Rights
3rd Mar 202610:46 amRNSTotal Voting Rights
2nd Mar 20269:00 amRNSBoard Appointment
16th Feb 202610:43 amRNSChange of Adviser
4th Feb 202612:54 pmRNSHolding(s) in Company
2nd Feb 20264:13 pmRNSTotal Voting Rights
30th Jan 20263:43 pmRNSHolding(s) in Company
23rd Jan 202612:02 pmRNSDirector/PDMR Shareholding
20th Jan 20264:15 pmRNSDirector/PDMR Shareholding
20th Jan 20267:00 amRNSWise Q3 FY26 trading update
19th Jan 20263:12 pmRNSDirector/PDMR Shareholding
2nd Jan 20261:11 pmRNSTotal Voting Rights
3rd Dec 202512:53 pmRNSDirector/PDMR Shareholding
1st Dec 20252:57 pmRNSTotal Voting Rights
21st Nov 202512:35 pmRNSPublication of pricing supplements
18th Nov 20255:00 pmRNSDirector/PDMR Shareholding
13th Nov 20259:14 amRNSEstablishment of Euro Medium Term Note Programme
10th Nov 202510:28 amRNSDirector/PDMR Shareholding
7th Nov 20253:24 pmRNSDirector/PDMR Shareholding
6th Nov 20257:00 amRNSFY26 Half Year Results
3rd Nov 20254:35 pmRNSTotal Voting Rights
16th Oct 20255:20 pmRNSDirector/PDMR Shareholding
10th Oct 20251:46 pmRNSTotal Voting Rights
9th Oct 20252:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20253:36 pmRNSDirector/PDMR Shareholding
25th Sep 20253:31 pmRNSResult of AGM
23rd Sep 20253:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.